Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.

MLA

Watanabe, Kenji, et al. “Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.” Journal of Crohn’s & Colitis, vol. 18, no. 6, June 2024, pp. 801–11. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjad201.

APA

Watanabe, K., Peyrin-Biroulet, L., Danese, S., Fujitani, Y., Faes, M., Oortwijn, A., Lindsay, J. O., Rogler, G., & Hibi, T. (2024). Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study. Journal of Crohn’s & Colitis, 18(6), 801–811. https://doi.org/10.1093/ecco-jcc/jjad201

Chicago

Watanabe, Kenji, Laurent Peyrin-Biroulet, Silvio Danese, Yasushi Fujitani, Margaux Faes, Alessandra Oortwijn, James O Lindsay, Gerhard Rogler, and Toshifumi Hibi. 2024. “Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.” Journal of Crohn’s & Colitis 18 (6): 801–11. doi:10.1093/ecco-jcc/jjad201.